vs
Lifeway Foods, Inc.（LWAY）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Lifeway Foods, Inc.的1.4倍（$75.5M vs $55.4M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 18.0%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-17.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 11.4%）
来福威食品公司是一家总部位于美国伊利诺伊州的健康食品企业，成立于1986年，是美国业内领先的开菲尔发酵益生菌产品供应商，这类产品主要用于调节人体微生物群平衡。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LWAY vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$55.4M
营收增速更快
PBYI
高出9.8%
18.0%
自由现金流更多
PBYI
多$31.8M
$-17.4M
两年增速更快
PBYI
近两年复合增速
11.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.4M | $75.5M |
| 净利润 | $2.5M | — |
| 毛利率 | 27.8% | 69.3% |
| 营业利润率 | 6.8% | 22.7% |
| 净利率 | 4.6% | — |
| 营收同比 | 18.0% | 27.7% |
| 净利润同比 | 1688.1% | — |
| 每股收益（稀释后） | $0.15 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LWAYPBYI
| Q4 25 | $55.4M | $75.5M | ||
| Q3 25 | $57.1M | $54.5M | ||
| Q2 25 | $53.9M | $52.4M | ||
| Q1 25 | $46.1M | $46.0M | ||
| Q4 24 | $46.9M | $59.1M | ||
| Q3 24 | $46.1M | $80.5M | ||
| Q2 24 | $49.2M | $47.1M | ||
| Q1 24 | $44.6M | $43.8M |
净利润LWAYPBYI
| Q4 25 | $2.5M | — | ||
| Q3 25 | $3.5M | $8.8M | ||
| Q2 25 | $4.2M | $5.9M | ||
| Q1 25 | $3.5M | $3.0M | ||
| Q4 24 | $-160.0K | — | ||
| Q3 24 | $3.0M | $20.3M | ||
| Q2 24 | $3.8M | $-4.5M | ||
| Q1 24 | $2.4M | $-4.8M |
毛利率LWAYPBYI
| Q4 25 | 27.8% | 69.3% | ||
| Q3 25 | 28.7% | 77.7% | ||
| Q2 25 | 28.6% | 76.5% | ||
| Q1 25 | 23.9% | 77.1% | ||
| Q4 24 | 25.3% | 76.4% | ||
| Q3 24 | 25.7% | 63.9% | ||
| Q2 24 | 27.0% | 77.4% | ||
| Q1 24 | 25.8% | 75.5% |
营业利润率LWAYPBYI
| Q4 25 | 6.8% | 22.7% | ||
| Q3 25 | 8.8% | 17.6% | ||
| Q2 25 | 10.8% | 12.7% | ||
| Q1 25 | 3.4% | 8.7% | ||
| Q4 24 | 1.5% | 22.6% | ||
| Q3 24 | 9.1% | 27.4% | ||
| Q2 24 | 11.0% | -4.6% | ||
| Q1 24 | 8.0% | -5.3% |
净利率LWAYPBYI
| Q4 25 | 4.6% | — | ||
| Q3 25 | 6.2% | 16.2% | ||
| Q2 25 | 7.9% | 11.2% | ||
| Q1 25 | 7.7% | 6.5% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 6.5% | 25.2% | ||
| Q2 24 | 7.7% | -9.6% | ||
| Q1 24 | 5.4% | -11.0% |
每股收益（稀释后）LWAYPBYI
| Q4 25 | $0.15 | $0.26 | ||
| Q3 25 | $0.23 | $0.17 | ||
| Q2 25 | $0.28 | $0.12 | ||
| Q1 25 | $0.23 | $0.06 | ||
| Q4 24 | $0.00 | $0.40 | ||
| Q3 24 | $0.19 | $0.41 | ||
| Q2 24 | $0.25 | $-0.09 | ||
| Q1 24 | $0.16 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $85.8M | $130.3M |
| 总资产 | $105.6M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LWAYPBYI
| Q4 25 | $5.6M | $97.5M | ||
| Q3 25 | $23.0M | $94.4M | ||
| Q2 25 | $21.2M | $96.0M | ||
| Q1 25 | $19.4M | $93.2M | ||
| Q4 24 | $16.7M | $101.0M | ||
| Q3 24 | $20.6M | $96.7M | ||
| Q2 24 | $14.6M | $96.8M | ||
| Q1 24 | $12.0M | $107.2M |
总债务LWAYPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | $2.5M | $102.0M |
股东权益LWAYPBYI
| Q4 25 | $85.8M | $130.3M | ||
| Q3 25 | $82.8M | $115.3M | ||
| Q2 25 | $78.7M | $104.7M | ||
| Q1 25 | $74.2M | $97.1M | ||
| Q4 24 | $71.9M | $92.1M | ||
| Q3 24 | $71.5M | $71.1M | ||
| Q2 24 | $68.0M | $48.5M | ||
| Q1 24 | $63.5M | $51.0M |
总资产LWAYPBYI
| Q4 25 | $105.6M | $216.3M | ||
| Q3 25 | $109.5M | $202.9M | ||
| Q2 25 | $98.3M | $194.9M | ||
| Q1 25 | $93.7M | $196.2M | ||
| Q4 24 | $90.5M | $213.3M | ||
| Q3 24 | $91.3M | $220.7M | ||
| Q2 24 | $84.9M | $205.0M | ||
| Q1 24 | $82.8M | $214.1M |
负债/权益比LWAYPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | 0.04× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $267.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-17.4M | $14.4M |
| 自由现金流率自由现金流/营收 | -31.5% | 19.1% |
| 资本支出强度资本支出/营收 | 31.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.11× | — |
| 过去12个月自由现金流最近4个季度 | $-16.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流LWAYPBYI
| Q4 25 | $267.0K | $14.4M | ||
| Q3 25 | $6.9M | $9.7M | ||
| Q2 25 | $3.9M | $14.1M | ||
| Q1 25 | $-150.0K | $3.6M | ||
| Q4 24 | $-2.6M | $15.6M | ||
| Q3 24 | $7.5M | $11.0M | ||
| Q2 24 | $6.5M | $1.0M | ||
| Q1 24 | $1.5M | $11.2M |
自由现金流LWAYPBYI
| Q4 25 | $-17.4M | $14.4M | ||
| Q3 25 | $1.8M | $9.7M | ||
| Q2 25 | $1.6M | $14.1M | ||
| Q1 25 | $-2.4M | $3.6M | ||
| Q4 24 | $-3.8M | $15.6M | ||
| Q3 24 | $5.9M | $11.0M | ||
| Q2 24 | $5.1M | $1.0M | ||
| Q1 24 | $-923.0K | — |
自由现金流率LWAYPBYI
| Q4 25 | -31.5% | 19.1% | ||
| Q3 25 | 3.1% | 17.7% | ||
| Q2 25 | 3.0% | 26.8% | ||
| Q1 25 | -5.1% | 7.7% | ||
| Q4 24 | -8.2% | 26.4% | ||
| Q3 24 | 12.8% | 13.7% | ||
| Q2 24 | 10.4% | 2.1% | ||
| Q1 24 | -2.1% | — |
资本支出强度LWAYPBYI
| Q4 25 | 31.9% | 0.0% | ||
| Q3 25 | 9.0% | 0.0% | ||
| Q2 25 | 4.3% | 0.0% | ||
| Q1 25 | 4.8% | 0.1% | ||
| Q4 24 | 2.7% | 0.0% | ||
| Q3 24 | 3.3% | 0.0% | ||
| Q2 24 | 2.9% | 0.0% | ||
| Q1 24 | 5.5% | 0.0% |
现金转化率LWAYPBYI
| Q4 25 | 0.11× | — | ||
| Q3 25 | 1.96× | 1.10× | ||
| Q2 25 | 0.92× | 2.41× | ||
| Q1 25 | -0.04× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.50× | 0.54× | ||
| Q2 24 | 1.73× | — | ||
| Q1 24 | 0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
PBYI
暂无分部数据
